High FIB-4 index as an independent risk factor of prevalent chronic kidney disease in patients with nonalcoholic fatty liver disease

被引：0
|
作者：
Huang-Wei Xu
Yung-Chien Hsu
Chia-Hao Chang
Kuo-Liang Wei
Chun-Liang Lin
机构：
[1] Chang Gung Memorial Hospital,Department of Nephrology and Kidney and Diabetic Complications Research Team (KDCRT)
[2] Chang Gung University College of Medicine,School of Traditional Chinese Medicine
[3] Chang Gung Memorial Hospital,Department of Hepato
[4] Chang Gung University of Science and Technology,Gastroenterology
来源：
Hepatology International | 2016年 / 10卷
关键词：
Non-alcoholic fatty liver disease; Chronic kidney disease; FIB-4; Liver fibrosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：340 / 346
页数：6
相关论文
共 50 条
  • [1] High FIB-4 index as an independent risk factor of prevalent chronic kidney disease in patients with nonalcoholic fatty liver disease
    Xu, Huang-Wei
    Hsu, Yung-Chien
    Chang, Chia-Hao
    Wei, Kuo-Liang
    Lin, Chun-Liang
    [J]. HEPATOLOGY INTERNATIONAL, 2016, 10 (02) : 340 - 346
  • [2] Correlation of Fibroscan with FIB-4 index for Assessment of Liver Fibrosis in patients with Nonalcoholic Fatty Liver Disease
    Tripathi, Brijendra Krishna
    Soni, Abhilasha
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 287 - 287
  • [3] Is nonalcoholic fatty liver disease a risk factor for chronic kidney disease?
    Ozturk, Kadir
    Demirci, Hakan
    Kurt, Omer
    Kantarcioglu, Murat
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (05) : 608 - 609
  • [4] Nonalcoholic fatty liver disease: A risk factor for chronic kidney disease
    Carvalho, Kellyane Dias
    Daltro, Carla
    Rocha, Raquel
    Cotrim, Helma P.
    [J]. ANNALS OF HEPATOLOGY, 2023, 28 (05)
  • [5] FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease
    Seko, Yuya
    Yano, Kohta
    Takahashi, Aya
    Okishio, Shinya
    Kataoka, Seita
    Okuda, Keiichiroh
    Mizuno, Naoki
    Takemura, Masashi
    Taketani, Hiroyoshi
    Umemura, Atsushi
    Nishikawa, Taichiro
    Yamaguchi, Kanji
    Moriguchi, Michihisa
    Okanoue, Takeshi
    Itoh, Yoshito
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (01)
  • [6] The Appropriate Opportunity for Evaluating Liver Fibrosis by Using the FIB-4 Index in Patients with Nonalcoholic Fatty Liver Disease in Japan
    Seko, Yuya
    Yano, Kota
    Takahashi, Aya
    Okishio, Shinya
    Kataoka, Seita
    Okuda, Keiichiroh
    Umemura, Atsushi
    Yamaguchi, Kanji
    Moriguchi, Michihisa
    Tanaka, Saiyu
    Itoh, Yoshito
    [J]. DIAGNOSTICS, 2020, 10 (10)
  • [7] FIB-4 Predicts MACE and Cardiovascular Mortality in Patients With Nonalcoholic Fatty Liver Disease
    Chew, Nicholas W. S.
    Ng, Cheng Han
    Chan, Kai En
    Chee, Douglas
    Syn, Nicholas
    Tamaki, Nobuharu
    Muthiah, Mark
    Noureddin, Mazen
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2022, 38 (11) : 1779 - 1780
  • [8] The FIB-4 Index Is a Useful Predictor for the Development of Hepatocellular Carcinoma in Patients with Coexisting Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B
    Kim, Minah
    Lee, Yeonju
    Yoon, Jun Sik
    Lee, Minjong
    Kye, So Shin
    Kim, Sun Woong
    Cho, Yuri
    [J]. CANCERS, 2021, 13 (10)
  • [9] RISK FACTORS FOR SIGNIFICANT FIBROSIS IN NONALCOHOLIC FATTY LIVER DISEASE WITH A LOW FIB-4 LEVEL
    Kim, Byung Ik
    Cho, Yong Kyun
    Cho, Ju-Yeon
    Kim, Jung Hee
    Jeong, Jae Yoon
    Oh, Hyunwoo
    Lee, Hyo Young
    Sohn, Won
    [J]. HEPATOLOGY, 2022, 76 : S729 - S730
  • [10] The combination of the enhanced liver fibrosis and FIB-4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease
    Younossi, Zobair M.
    Stepanova, Maria
    Felix, Sean
    Jeffers, Thomas
    Younossi, Elena
    Goodman, Zachary
    Racila, Andrei
    Lam, Brian P.
    Henry, Linda
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (12) : 1417 - 1422
12345